A Long-term, Confirmatory, Phase 3, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study To Investigate The Safety And Efficacy Of Orally Administered Sd-6010 In Subjects With Symptomatic Osteoarthritis Of The Knee.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Cindunistat (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 24 Jan 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Sep 2011 New trial record